000 | 01950 a2200481 4500 | ||
---|---|---|---|
005 | 20250511192741.0 | ||
264 | 0 | _c19920528 | |
008 | 199205s 0 0 eng d | ||
022 | _a0732-183X | ||
024 | 7 |
_a10.1200/JCO.1992.10.5.706 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAlberts, D S | |
245 | 0 | 0 |
_aImproved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer. _h[electronic resource] |
260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cMay 1992 |
||
300 |
_a706-17 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 |
_aCarboplatin _xadministration & dosage |
650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
650 | 0 | 4 | _aReoperation |
650 | 0 | 4 | _aSurvival Analysis |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aGreen, S | |
700 | 1 | _aHannigan, E V | |
700 | 1 | _aO'Toole, R | |
700 | 1 | _aStock-Novack, D | |
700 | 1 | _aAnderson, P | |
700 | 1 | _aSurwit, E A | |
700 | 1 | _aMalvlya, V K | |
700 | 1 | _aNahhas, W A | |
700 | 1 | _aJolles, C J | |
773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 10 _gno. 5 _gp. 706-17 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.1992.10.5.706 _zAvailable from publisher's website |
999 |
_c1575926 _d1575926 |